Northstack Editorial

Northstack Editorial

The Memo: Coders of the Future and Technical Talent

Happy PokéMonday everyone. Hope your Pokemon catches have been going well — mine have. Last week I traveled a bit around the country with an American friend. We both visited the Glacier Lagoon and the Golden circle, great places. Sadly, neither had any cool Pokemon’s, which was quite the disappointment.

Book Club Notes: The Power of Habit

Norðurskautið Book Club had its first meetup recently. We discussed the book The Power of Habit by Charles Duhigg. The book tells the story of habits, both personal and organizational. It discusses how powerful habits are in our day-to-day lives, and how you can change yours to the better. It’

The Memo: Where are the community driven startup events?

Last week, Óli Johnson, co-founder of Rainmaking Loft and Catapult, was in Iceland. One of his stops was a breakfast meetup at Startup Reykjavik where he discussed community building. I couldn’t make it, but met up with him (Daði joined as well) later. Sign up for the Memo. As

The Memo: First look at Startup Reykjavik

Sorry for being late with this week’s Memo. I had a very busy weekend. Also, I was at RÚV’s Morgunútvarpið this morning (link) discussing Norðurskautið and startup funding in Iceland (Icelandic). Now, on to the Memo. Startup Reykjavik kicked off Last week saw the first public event of

Data Dwell secures $1.2m in funding

Digital asset management (DAM) company Data Dwell has secured a $1.12m (140m ISK) funding round by Frumtak Ventures. The company also received a $80K (10m ISK) marketing grant from the Technology Development Fund. “We think Data Dwell has enormous growth potential and like the product offering,” Eggert Claessen, GP

The Memo: Analysing the Funding Report

I’ll start of by apologizing for the lack of Memo’s in the last two weeks! I was away in the north west of Iceland, with no access to internet. We held our first book club last week. It was pretty good — I’ll post a key take-aways post

Pharmaceutical company 3Z raises $400K seed round

3Z pharmaceuticals has closed a $400K seed round. The investors were Swiss biotech companies Baliopharm and Probiocon, as well as previous investors NSA Ventures and Sigþór Sigmarsson. “3Z offers a unique technology to speed up the development of innovative drugs for the treatment of all kind of neurological disorders,” says